IL82893A0 - Use of specific immunomodulators in treating viral-induced immunodeficiencies - Google Patents

Use of specific immunomodulators in treating viral-induced immunodeficiencies

Info

Publication number
IL82893A0
IL82893A0 IL82893A IL8289387A IL82893A0 IL 82893 A0 IL82893 A0 IL 82893A0 IL 82893 A IL82893 A IL 82893A IL 8289387 A IL8289387 A IL 8289387A IL 82893 A0 IL82893 A0 IL 82893A0
Authority
IL
Israel
Prior art keywords
treating viral
specific immunomodulators
immunodeficiencies
induced
induced immunodeficiencies
Prior art date
Application number
IL82893A
Other languages
English (en)
Original Assignee
New Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Therapeutics Ltd filed Critical New Therapeutics Ltd
Publication of IL82893A0 publication Critical patent/IL82893A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL82893A 1986-06-17 1987-06-16 Use of specific immunomodulators in treating viral-induced immunodeficiencies IL82893A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868614733A GB8614733D0 (en) 1986-06-17 1986-06-17 Aids treatment

Publications (1)

Publication Number Publication Date
IL82893A0 true IL82893A0 (en) 1987-12-20

Family

ID=10599595

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82893A IL82893A0 (en) 1986-06-17 1987-06-16 Use of specific immunomodulators in treating viral-induced immunodeficiencies

Country Status (11)

Country Link
EP (1) EP0250234A1 (fr)
JP (1) JPS6360932A (fr)
AU (1) AU7441587A (fr)
CH (1) CH673396A5 (fr)
DE (1) DE3720434A1 (fr)
DK (1) DK308687A (fr)
FR (1) FR2599971B1 (fr)
GB (2) GB8614733D0 (fr)
IL (1) IL82893A0 (fr)
NO (1) NO872541L (fr)
PT (1) PT85115A (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284664A (en) * 1988-08-04 1994-02-08 Kremers-Urban Company Method of treating the symptoms of Alzheimer's disease
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
US5334395A (en) * 1988-08-04 1994-08-02 Kremers-Urban Company Method of treating an epstein-barr viral infection
DE3827490A1 (de) * 1988-08-12 1990-02-15 Hor Fer Vit Pharma Gmbh Herrichtung und verwendung eines physiologisch aktiven polypeptids zur aids-therapie
EP0537722A3 (en) * 1991-10-15 1994-07-13 Kremers Urban Co Porcane liver polypeptides for treating viral infections
WO2004041071A2 (fr) * 2002-11-04 2004-05-21 4Life Research, Lc Compositions, systemes et methodes permettant de focaliser une reponse immunitaire a mediation cellulaire

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073293B1 (fr) * 1969-12-31 1973-01-12 Pasteur Institut
US3991182A (en) * 1971-10-19 1976-11-09 The Regents Of The University Of California Transfer factor
GB1443948A (en) * 1972-10-20 1976-07-28 Piktor Ltd Production of immunological material
GB1592954A (en) * 1976-12-16 1981-07-15 Int Inst Of Differentiation Cell line
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4180627A (en) * 1978-08-17 1979-12-25 The United States Of America As Represented By The Secretary Of Agriculture Process for in vivo transfer of cell-mediated immunity in mammals with alcoholic precipitates of Bovine Transfer factor
WO1980000790A1 (fr) * 1978-10-25 1980-05-01 Benzon As Alfred Facteur de transfert et procede de preparation
IE53572B1 (en) * 1980-05-14 1988-12-21 Arthur Gottlieb A Modulators of the immune system
US4323555A (en) * 1980-11-03 1982-04-06 The Regents Of The University Of California Method of protecting cattle and sheep against bovine leukemia virus and vaccines for use therein
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system
JPS5967226A (ja) * 1982-07-20 1984-04-16 デイミトリ・ビザ ウイルス感染処置に使用する転移因子
US4521407A (en) * 1983-08-29 1985-06-04 Serono Pharmaceutical Partners Treatment of acquired immune deficiency syndrome with thymus extract
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens

Also Published As

Publication number Publication date
NO872541L (no) 1987-12-18
PT85115A (en) 1987-07-01
GB8614733D0 (en) 1986-07-23
DK308687D0 (da) 1987-06-17
CH673396A5 (fr) 1990-03-15
AU7441587A (en) 1987-12-24
GB2193498A (en) 1988-02-10
DE3720434A1 (de) 1987-12-23
GB8714181D0 (en) 1987-07-22
EP0250234A1 (fr) 1987-12-23
NO872541D0 (no) 1987-06-17
FR2599971B1 (fr) 1990-11-30
DK308687A (da) 1987-12-18
FR2599971A1 (fr) 1987-12-18
JPS6360932A (ja) 1988-03-17

Similar Documents

Publication Publication Date Title
EP0234938A3 (en) Application of tetrathiafulvalenes in bioelectrochemical processes
GB8710168D0 (en) Cryogenic treatment of skin
GB2197647B (en) Improvements in or relating to water treatment devices
GB8600822D0 (en) Treatment of skin disorders
NZ213983A (en) Treatment of t-lymphocytes
GB8627175D0 (en) Treatment of inorganic particles
EP0272013A3 (en) Waste treatment
PT85115A (en) Use of specific immunomodulators in treating viral-induced immunodeficiencies
GB8807328D0 (en) Improvements in treatment of hair
GB2190682B (en) Treatment of bio-gas
GB8626356D0 (en) Treatment of hair
EP0270470A3 (en) Massage method and implement
GB8500292D0 (en) Treatment of babesiosis
EP0253517A3 (en) Treatment of giardiasis
GB8617623D0 (en) Treatment
IE871606L (en) Use of specific immunomodulators in treating viral-induced¹immunodeficiencies
AU8094887A (en) Water treatment compositions and processes
ZA871492B (en) Treatment of waste water
GB2175808B (en) Treatment tables
IL84557A0 (en) Water treatment compositions and processes
EP0254777A3 (en) Use of imidazolinylaminoisoindolines and related compounds in the treatment of hyperglycaemia
GB2187203B (en) Application of tetrathiafulvalenes in bioelectrochemical processes
GR862403B (en) Water treatment method and product
GB8603711D0 (en) Treatment of can labels
GB2188312B (en) Improvements in or relating to the treatment of waters